Creation of the recombinant tissue plasminogen activator (rt-PA) image and its influence on practice habits

This publication has 37 references indexed in Scilit:

• Management of acute myocardial infarction 1990: A perspective
  Clinical Cardiology, 1991
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• A multicenter trial of intravenous APSAC versus rtPA in acute myocadial infarction. Assessment of efficacy and safety
  Journal of the American College of Cardiology, 1990
• Thrombolytic Agents in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial Infarction
  New England Journal of Medicine, 1989
• Six- and twelve-month follow-up of the phase I thrombolysis in myocardial infarction (TIMI) trial
  The American Journal of Cardiology, 1988
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988
• Recombinant tissue plasminogen activator (rt-PA): Is it the thrombolytic agent of choice for an evolving acute myocardial infarction?
  The American Journal of Cardiology, 1987
• The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.
  Circulation, 1987
• Tissue Plasminogen Activator (t-PA)
  New England Journal of Medicine, 1985